Reagents and consumables

Ended Awarded

Contract number
75N91023F00004
Awardee
Awarding agency
Obligated
$20,464

Award facts

Contract value 100% obligated
$20,463.87 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded Roche Diagnostics Corporation a $20,463.87 firm fixed price delivery order for reagents and consumables. The contract has no set-aside designation and runs through January 13, 2023. As the largest biomedical research agency in the world, the National Cancer Institute works with both public and private partners to better understand, diagnose, and treat cancer. This delivery order supports the critical work of the Institute by providing needed laboratory supplies to its research programs.

Quick answers

Who was awarded contract 75N91023F00004?

75N91023F00004 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on December 14, 2022.

How much is contract 75N91023F00004 worth?

The government has obligated $20,464 on 75N91023F00004.

Is contract 75N91023F00004 an order under another contract?

Yes. 75N91023F00004 is a delivery order under 75N91019D00038, an indefinite delivery contract.

Was contract 75N91023F00004 competed?

The extent of competition for 75N91023F00004 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award